These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 20619342)

  • 1. Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates.
    Dissette V; Bozzi P; Bignozzi CA; Dalpiaz A; Ferraro L; Beggiato S; Leo E; Vighi E; Pasti L
    Eur J Pharm Sci; 2010 Oct; 41(2):328-36. PubMed ID: 20619342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate.
    Kanatsu K; Aihara E; Okayama M; Kato S; Takeuchi K
    J Gastroenterol Hepatol; 2004 May; 19(5):512-20. PubMed ID: 15086594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionic complex of risedronate with positively charged deoxycholic acid derivative: evaluation of physicochemical properties and enhancement of intestinal absorption in rats.
    Park JW; Byun Y
    Arch Pharm Res; 2014 Dec; 37(12):1560-9. PubMed ID: 24254935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of administration site in the gastrointestinal tract on bioavailability of poorly absorbed drugs taken after a meal.
    Sakuma S; Tanno FK; Masaoka Y; Kataoka M; Kozaki T; Kamaguchi R; Kokubo H; Yamashita S
    J Control Release; 2007 Mar; 118(1):59-64. PubMed ID: 17250919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
    Rendina D; Mossetti G; Viceconti R; Sorrentino M; Nunziata V
    Calcif Tissue Int; 2004 Sep; 75(3):189-96. PubMed ID: 15148558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particle size determination of sunscreens formulated with various forms of titanium dioxide.
    Wokovich A; Tyner K; Doub W; Sadrieh N; Buhse LF
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1180-9. PubMed ID: 19555241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo.
    Fournier PG; Daubiné F; Lundy MW; Rogers MJ; Ebetino FH; Clézardin P
    Cancer Res; 2008 Nov; 68(21):8945-53. PubMed ID: 18974139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR; Miller P; Lyles K; Fraser W; Brown JP; Saidi Y; Mesenbrink P; Su G; Pak J; Zelenakas K; Luchi M; Richardson P; Hosking D
    N Engl J Med; 2005 Sep; 353(9):898-908. PubMed ID: 16135834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of floating risedronate sodium Gelucire 39/01 matrices.
    Chauhan B; Shimpi S; Mahadik K; Paradkar A
    Acta Pharm; 2004 Sep; 54(3):205-14. PubMed ID: 15610617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
    Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
    Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates.
    Rietbrock S; Olson M; van Staa TP
    QJM; 2009 Jan; 102(1):35-42. PubMed ID: 18842684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo.
    Wakchoure S; Merrell MA; Aldrich W; Millender-Swain T; Harris KW; Triozzi P; Selander KS
    Clin Cancer Res; 2006 May; 12(9):2862-8. PubMed ID: 16675582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
    Yang L; Geng Y; Li H; Zhang Y; You J; Chang Y
    Pharmazie; 2009 Feb; 64(2):86-9. PubMed ID: 19320279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.
    Erben RG; Mosekilde L; Thomsen JS; Weber K; Stahr K; Leyshon A; Smith SY; Phipps R
    J Bone Miner Res; 2002 Aug; 17(8):1498-511. PubMed ID: 12162504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration.
    Bu Q; Yan G; Deng P; Peng F; Lin H; Xu Y; Cao Z; Zhou T; Xue A; Wang Y; Cen X; Zhao YL
    Nanotechnology; 2010 Mar; 21(12):125105. PubMed ID: 20203358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the physicochemical properties and oral bioavailability of the solid dispersion of cantharidin with polyethylene glycol 4000.
    Dang YJ; Hu CH; An LN; Zhu CY
    Methods Find Exp Clin Pharmacol; 2010 Apr; 32(3):157-62. PubMed ID: 20448857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extemporaneous procedures for dissolving risedronate tablets for oral administration and for feeding tubes.
    Dansereau RJ; Crail DJ
    Ann Pharmacother; 2005 Jan; 39(1):63-7. PubMed ID: 15590875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocrystalline titanium dioxide and magnesium oxide in vitro dermal absorption in human skin.
    van der Merwe D; Tawde S; Pickrell JA; Erickson LE
    Cutan Ocul Toxicol; 2009; 28(2):78-82. PubMed ID: 19514931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cogrinding enhances the oral bioavailability of EMD 57033, a poorly water soluble drug, in dogs.
    Vogt M; Vertzoni M; Kunath K; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2008 Feb; 68(2):338-45. PubMed ID: 17646091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the microscopic equilibrium dissociation constants for risedronate and its analogues reveals two distinct roles for the nitrogen atom in nitrogen-containing bisphosphonate drugs.
    Hounslow AM; Carran J; Brown RJ; Rejman D; Blackburn GM; Watts DJ
    J Med Chem; 2008 Jul; 51(14):4170-8. PubMed ID: 18590315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.